Association of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on LVAD Support and Risk of Gastrointestinal Bleeding: A Multi-Center Analysis

We have previously reported an association between angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) use and reduced rates of gastrointestinal bleeding (GIB) after the left ventricular assist device (LVAD) implantation. The purpose of this analysis was to test this association in a large, multi-center database inclusive of HeartMate 3 devices.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: J.N. Schultz, B. Trachtenberg, J. Estep, K. Goodwin, R. Araujo, A.G.El Rafei, M. Pritzker, F. Kamdar, R. John, R. Cogswell Tags: (41) Source Type: research